BRIGHT MINDS BIOSCIENCES INC.
DRUG$897M
Small CapNASDAQBiotechnology🇺🇸North America26 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 25, 2026
16wMarket Overview
Stock performance and key metrics
DRUG News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
BMB-101 | Phase 2 | Absence Epilepsy | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply